Loading
Medicenna Therapeutics Corp. Stock: price and insider trades · Canada
CA·Mcap CA$36.5M
Medicenna Therapeutics Corp.: what insiders have been doing
Medicenna Therapeutics Corp. is a listed company. Filings by its managers are published through SEDI. Between 18 October 2025 and 18 October 2026, 5 insiders published 14 filings.
Not one of the filings records a straightforward purchase or sale on the market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
Compared with its exchange (2,130 companies, median 12 filings), a count of 14 filings is above the norm.
No insider has bought Medicenna Therapeutics Corp. shares on the open market in the past twelve months. Filings reach the SEDI feed a median of 5 days after the trade. That lag is the time during which only the insider knows about the trade.
This summary is built from SEDI disclosures alone and does not predict where the share price will go.
Insider Decl.
14
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2026FY ended March 2026 · cache
CA$0.40
Analyst consensus
3 analysts1.00/5
CA$1.60Target CA$3.20(+710%)CA$4.00
Income statement
EBITDA-CA$22.3M
Net income-CA$18.4M0.0% margin
Valuation
P/Book21.9x
Beta1.96
Balance sheet & cash
Market capCA$36.5M
Total debtCA$119k
Free Cash Flow-CA$17.9M
Debt / Equity6%
Profitability & ownership
ROE-227.6%
ROA-90.1%
% insiders18.8%
% institutions0.0%
Last declaration on 2 June 2026
Declarations14 total
55,000 shares@ CA$0.6539.4% of flowWarrantsTSXSEDI:4727209
WarrantsTSXSEDI:4727208
110,000 shares@ CA$0.5060.6% of flowCommon SharesTSXSEDI:4727207
200,000 shares@ CA$0.6539.4% of flowWarrantsTSXSEDI:4727169
400,000 shares@ CA$0.5060.6% of flowCommon SharesTSXSEDI:4727161
10,000 shares@ CA$0.6539.4% of flowWarrantsTSXSEDI:4727150
WarrantsTSXSEDI:4727144
20,000 shares@ CA$0.5060.6% of flowCommon SharesTSXSEDI:4727141
10,000 shares@ CA$0.6539.4% of flowWarrantsTSXSEDI:4727138
WarrantsTSXSEDI:4727132
20,000 shares@ CA$0.5060.6% of flowCommon SharesTSXSEDI:4727122
25,000 sharesWarrantsTSXSEDI:4726822
WarrantsTSXSEDI:4726820
50,000 shares@ CA$0.05100.0% of flowCommon SharesTSXSEDI:4726819
14 of 14 declarations
About Medicenna Therapeutics Corp.
Medicenna Therapeutics Corp. is a biopharmaceutical company focused on developing cytokine-based therapies for cancer treatment. It is listed on the Toronto Stock Exchange under the symbol MDNA.
